SUDHIR SEKHON, MD
Hematology & Oncology Physician · PEORIA, IL
Individual Active NPI 1598763955
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 478 | 126,822 | $14,261,183 | $3,868,611 | $3,081,517 |
| 2023 | 325 | 84,468 | $8,198,694 | $1,944,387 | $1,547,680 |
| 2022 | 133 | 9,249 | $579,276 | $153,812 | $122,214 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 17,600 | $56 | $45 |
| J1453 | Injection, fosaprepitant, 1 mg | 11,550 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 10,680 | $31 | $25 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 7,702 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 6,837 | $0 | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 4,600 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 3,540 | $26 | $21 |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,230 | $20 | $16 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,608 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,230 | $1 | $1 |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 420 | $71 | $56 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 415 | $131 | $104 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 036-091734 | IL |
| Hematology & Oncology Physician | 207RH0003X | ME 84762 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Illinois
- NPI 1396744611
- NPI 1871593434
- NPI 1487633251
- NPI 1629288659
- NPI 1245239565
- NPI 1285633503
- NPI 1043474042
- NPI 1083613947
See all Hematology & Oncology Physician providers in Illinois →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.